These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19741185)

  • 1. Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.
    Calvin AD; Aggarwal NR; Murad MH; Shi Q; Elamin MB; Geske JB; Fernandez-Balsells MM; Albuquerque FN; Lampropulos JF; Erwin PJ; Smith SA; Montori VM
    Diabetes Care; 2009 Dec; 32(12):2300-6. PubMed ID: 19741185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.
    Kunutsor SK; Seidu S; Khunti K
    Diabet Med; 2017 Mar; 34(3):316-327. PubMed ID: 27086572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
    Zhang C; Sun A; Zhang P; Wu C; Zhang S; Fu M; Wang K; Zou Y; Ge J
    Diabetes Res Clin Pract; 2010 Feb; 87(2):211-8. PubMed ID: 19853947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.
    Younis N; Williams S; Soran H
    Diabetes Obes Metab; 2009 Nov; 11(11):997-1000. PubMed ID: 19531055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.
    Butalia S; Leung AA; Ghali WA; Rabi DM
    Cardiovasc Diabetol; 2011 Apr; 10():25. PubMed ID: 21453547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials.
    Seidu S; Kunutsor SK; Sesso HD; Gaziano JM; Buring JE; Roncaglioni MC; Khunti K
    Cardiovasc Diabetol; 2019 Jun; 18(1):70. PubMed ID: 31159806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis.
    Khan SU; Ul Abideen Asad Z; Khan MU; Talluri S; Ali F; Shahzeb Khan M; Lone AN; Mookadam F; Krasuski RA; Kaluski E
    Eur J Prev Cardiol; 2020 Dec; 27(19):2034-2041. PubMed ID: 30700151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
    Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
    Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis.
    Caldeira D; Alves M; David C; Costa J; Ferreira JJ; Pinto FJ
    Prim Care Diabetes; 2020 Jun; 14(3):213-221. PubMed ID: 31791903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aspirin on mortality in the primary prevention of cardiovascular disease.
    Raju N; Sobieraj-Teague M; Hirsh J; O'Donnell M; Eikelboom J
    Am J Med; 2011 Jul; 124(7):621-9. PubMed ID: 21592450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials.
    Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML
    High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and Risks Associated With Aspirin Use in Patients With Diabetes for the Primary Prevention of Cardiovascular Events and Mortality: A Meta-Analysis.
    Ma H; Gu Q; Niu H; Li X; Wang R
    Front Endocrinol (Lausanne); 2021; 12():741374. PubMed ID: 34539583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.
    De Berardis G; Sacco M; Strippoli GF; Pellegrini F; Graziano G; Tognoni G; Nicolucci A
    BMJ; 2009 Nov; 339():b4531. PubMed ID: 19897665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and Risks Associated with Low-Dose Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis.
    Wang M; Yu H; Li Z; Gong D; Liu X
    Am J Cardiovasc Drugs; 2022 Nov; 22(6):657-675. PubMed ID: 35570250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups.
    Gelbenegger G; Postula M; Pecen L; Halvorsen S; Lesiak M; Schoergenhofer C; Jilma B; Hengstenberg C; Siller-Matula JM
    BMC Med; 2019 Nov; 17(1):198. PubMed ID: 31679516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
    Sacco M; Pellegrini F; Roncaglioni MC; Avanzini F; Tognoni G; Nicolucci A;
    Diabetes Care; 2003 Dec; 26(12):3264-72. PubMed ID: 14633812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
    Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
    JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.